Author: HUTCHMED (China) Limited

— HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action — — Lead candidate HMPL-A251 harnesses a selective PI3K/PIKK inhibitor payload, demonstrating promising preclinical efficacy and safety — — Progress in global and China trials, including FRUSICA-2, SANOVO, surufatinib’s PDAC and fanregratinib’s IHCC studies, advances HUTCHMED’s late-stage pipeline — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 02, 2025 (GLOBERead More

Read More

The 5-2 Seahawks and 3-5 Commanders meet in this week’s Sunday Night Football, kicking off at 8:20 p.m. EST. Seattle has proven itself as one of the top teams in the NFC and is hoping to stay atop the NFC West standings. Washington, currently 3-5, is hoping to stay in the playoff race after making […]Read More

Read More

The former Bengals receiver-turned-broadcaster, who died Sunday at age 80, hosted sports shows on WCKY-AM and WLW-AM before joining NBC Sports full-time and becoming NBC’s No. 1 NFL analyst. He paved the way for NFL analysts Cris Collinsworth, Dave Lapham, Sam Wyche, and Solomon Wilcots.Read More

Read More